Physician profile
Joseph Watson
NPI 1124516513
$5,808.90
in general payments reported to CMS, 2019-2025
15 companies · $504 in 2025
The $504 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.51 · 2024: $5,274 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,669 · Travel and Lodging: $1,609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,668.51 |
| Travel and Lodging | $1,608.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,522.99 | 2024 | |
| Grifols USA, LLC | $2,317.69 | 2024 | Prolastin-C Liquid |
| Abiomed | $220.63 | 2019-2025 | |
| Pulmonx Corporation | $165.82 | 2024-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Chartis Catheter |
| Insmed, INC. | $158.03 | 2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $156.56 | 2024 | Orenitram, Remodulin |
| Astrazeneca Pharmaceuticals LP | $53.24 | 2024-2025 | Airsupra |
| Mallinckrodt Hospital Products INC. | $37.91 | 2024 | Acthar |
| Inspire Medical Systems, INC. | $34.94 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $33.42 | 2024 | Keytruda |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.17 | 2025 | Ofev, Jascayd |
| Amgen INC. | $24.79 | 2024 | Tezspire |
| Janssen Pharmaceuticals, INC | $18.90 | 2024 | Xarelto |
| Genzyme Corporation | $17.08 | 2024 | |
| Glaxosmithkline, LLC. | $15.73 | 2024 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.